Galmed Pharmaceutica (GLMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,855 | 2,998 | 3,603 | 8,036 | 13,498 |
| Marketable Securities | 25,001 | 31,931 | 38,415 | 41,333 | 43,614 |
| Receivables | 843 | 1,125 | 1,674 | 487 | 784 |
| Other current assets | 0 | 0 | 0 | 1,809 | 1,806 |
| TOTAL | $29,699 | $36,054 | $43,692 | $51,665 | $59,702 |
| Non-Current Assets | |||||
| PPE Net | 136 | 145 | 154 | 163 | 166 |
| Other Non-Current Assets | 361 | 406 | 452 | 497 | 509 |
| TOTAL | $497 | $551 | $606 | $660 | $675 |
| Total Assets | $30,196 | $36,605 | $44,298 | $52,325 | $60,377 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,647 | 5,879 | 6,348 | 7,008 | 7,137 |
| TOTAL | $5,647 | $5,879 | $6,348 | $7,008 | $7,137 |
| Non-Current Liabilities | |||||
| TOTAL | $183 | $229 | $274 | $318 | $283 |
| Total Liabilities | $5,830 | $6,108 | $6,622 | $7,326 | $7,420 |
| Shareholders' Equity | |||||
| Common Shares | 70 | 70 | 70 | 70 | 70 |
| Retained earnings | -174,317 | -168,174 | -160,722 | -153,008 | -144,612 |
| Other shareholders' equity | -616 | -171 | -75 | 108 | 142 |
| TOTAL | $24,366 | $30,497 | $37,676 | $44,999 | $52,957 |
| Total Liabilities And Equity | $30,196 | $36,605 | $44,298 | $52,325 | $60,377 |